A study of human tumor cells implanted in mice from the MacPherson Lab at Fred Hutch describes a new way to screen for the ...

A study published in the journal Cell marks the first reported instance of generative AI designing synthetic molecules that ...

The University of Bayreuth's Biomaterials research group has, for the first time, successfully applied the CRISPR-Cas9 ...

Nkure Therapeutics and Crispr Therapeutics partner to develop off-the-shelf CAR T therapy for oncology in India.

NKure Therapeutics & CRISPR Therapeutics partner to advance CTX112 for cancer treatment in India: Our Bureau, Bengaluru Wednesday, May 7, 2025, 13:45 Hrs [IST] NKure Therapeutics, ...

Effective mucosal immunity in the intestine involves a fine balance between tolerance of the microbiome, recognition and elimination of pathogens, and inflammatory tissue injury. The anti-inflammatory ...

The development paves the way to launch of commercial production of medicines, tentatively starting July 2025.

Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited tumor-infiltrating lymphocytes (TILs) may be ...

Researchers in Korea generated a new method for generating CHO cell lines with significantly higher productivity, efficiency, ...

Scientists have identified a key gene that regulates sugar metabolism and dramatically improves tomato fruit quality and ...

The CRISPR company is laying off about a third of its employees and stopping work on an experimental lupus treatment in a bid ...

Genomics company, Integrated DNA Technologies, is rewriting the future of genomics, pioneering new innovations in a bold move ...